Berenberg Bank reiterated their buy rating on shares of Aviva (LON:AV – Free Report) in a research note published on Monday morning, Marketbeat reports. The firm currently has a GBX 820 target price on the stock.
A number of other research analysts have also commented on the stock. Citigroup upped their price objective on shares of Aviva from GBX 671 to GBX 721 and gave the company a “neutral” rating in a research report on Wednesday, August 26th. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 780 target price on shares of Aviva in a research note on Monday, September 7th. Finally, JPMorgan Chase & Co. raised their price target on Aviva from GBX 715 to GBX 800 and gave the company an “overweight” rating in a report on Thursday, August 13th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Aviva presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 760.71.
Check Out Our Latest Analysis on Aviva
Aviva Price Performance
Insider Activity
In related news, insider Pippa Lambert acquired 210 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were bought at an average price of GBX 710 per share, for a total transaction of £1,491. Insiders bought a total of 484 shares of company stock valued at $348,286 over the last 90 days. 0.17% of the stock is currently owned by insiders.
About Aviva
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities.
Further Reading
- Five stocks we like better than Aviva
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
